Schwarz Mann, a biochemical supply company with considerable technical and commercial success, was purchased by Becton Dickinson in the 1970s and, like most growing companies that Becton Dickinson purchased, was ruined by the parent company whose executives lacked scientific training and perspective. Becton failed to invest in the biochemical supply business during a time when other companies in the business rapidly expanded and prospered. The Schwarz Mann business at Becton was located at 13 Mountain View Avenue, Orangeburg New York, just north of the New Jersey border.
Because the Schwarz Mann business involved, in part, radiocative biochemicals, Becton tried to use this base to vault into clinical diagnostics that used such chemicals. While the original Schwartz business atrophied, its skilled chemists made a success of the diagnostics business, for a while until the corporate people started interfering. Becton corporate management, based in Paramus and later at a palace like HQ in Franklin Lakes, formed a limited partnership of outside investors to develop a new type of diagnostic product based on a failed concept, a liposomal detection system. This detection system was developed by a Becton unit in Salt Lake City that had been purchased from Howard Hughs (!) and run into the ground by Becton corporate by the early 1980s. While the liposomal concept was flawed from the start, certain corporate executives were tied to its success and the whole affair took on an 'emperor who wore no clothes' atmosphere as staff was forced to pretend that the system worked, and middle managers presented phony data to support efficacy. Ultimately, an expensive and unworkable instrument was developed, called the Aria. It was pushed to market and was a dismal failure that died on the launch pad, because customers refused to go along with the ruse. Multiple Becton divisions were closed as a result of this fiasco. Perhaps five hundred careers were ruined in Orangeberg, Salt Lake, and Baltimore. But the corporate executives got their parachutes and one went on to lead a major American pharmaceutical company. At the end, many Schwartz Mann original employees were still present. So that is the sorry end of a proud company, Schwarz Mann, ground down to oblivion like most small entities that come within the orbit of Becton Dickinson under the pretense of synergy.
Currently the property on Mountainview Avenue, based on a Google search, does not appear to have a corporate owner, and may be in the hands of a non-profit. Since the building was used for high level radioactive chemical synthesis, I often wonder how, and if, the building ductwork was decommissioned of high radioactivity levels, and how the grounds, that were subject to many chemical dumpings over the years (especially outside the door behind what was the cafeteria) were cleaned up for sale.
Mann Gulch fire happened in 1949.
A biotech. engineer is concern with applications of living cells or their components for the benefit of society. In biothechnology there is the utilization of organisms or of substances obtained from them in industrial processes. A biotech. also works in the field of production of food crops, livestock management, human health care, chemical industries and enviormental management.
BIOVISION, BIOPROCEEDINGS..
Perhaps the MS in biotech. I was taught some biotech by a woman who had an MS in immunology and was a scientific manager at Genentec with many people under her.
i think its very difficult....
The cast of Misdroy - 2005 includes: Mirus Fitzner as Mann Andrea Hamann as Frau Jasper Lenz Radeke as Mann in Schwarz
Mann Gulch fire happened in 1949.
British Biotech's population is 500.
Ganeden Biotech was created in 1997.
British Biotech was created in 1986.
Braasch Biotech was created in 2008.
Janssen Biotech was created in 1979.
Oncolytics Biotech was created in 1998.
Axial Biotech was created in 2003.
The cast of Rottenknechte - 1971 includes: Volkmar Kleinert Ruth Kommerell Dieter Mann Dieter Montag Klaus Piontek Jaecki Schwarz
Hannes Schwarz has written: 'Hannes Schwarz'
Phalanx Biotech Group was created in 2003.